+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Blood Plasma Market - Global Strategic Business Report - Product Thumbnail Image

Blood Plasma Market - Global Strategic Business Report

  • Report
  • July 2026
  • 282 Pages
  • Global
From
From
From
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • July 2026
  • 196 Pages
  • Global
From
Thrombin - Global Strategic Business Report - Product Thumbnail Image

Thrombin - Global Strategic Business Report

  • Report
  • July 2026
  • 225 Pages
  • Global
From
Plasma Therapy - Global Strategic Business Report - Product Thumbnail Image

Plasma Therapy - Global Strategic Business Report

  • Report
  • July 2026
  • 275 Pages
  • Global
From
From
Global Markets for Blood Plasma Products - Product Thumbnail Image

Global Markets for Blood Plasma Products

  • Report
  • February 2023
  • 144 Pages
  • Global
From
Blood Plasma Derivatives Market - Global Forecast 2026-2032 - Product Thumbnail Image

Blood Plasma Derivatives Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Loading Indicator